PB9171
antibody from Boster Biological Technology
Targeting: CEBPB
C/EBP-beta, CRP2, IL6DBP, LAP, NFIL6, TCF5
Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PB9171 - Provider product page
- Provider
- Boster Biological Technology
- Product name
- Anti-CEBP Beta/CEBPB Antibody Picoband™
- Antibody type
- Polyclonal
- Description
- Polyclonal antibody for CEBP BETA/CEBPB detection. Host: Rabbit.Size: 100μg/vial. Tested applications: IHC-P. Reactive species: Human. CEBP BETA/CEBPB information: Molecular Weight: 36106 MW; Subcellular Localization: Nucleus . Cytoplasm . Translocates to the nucleus when phosphorylated at Ser-288. In T-cells when sumoylated drawn to pericentric heterochromatin thereby allowing proliferation (By similarity); Tissue Specificity: Expressed at low levels in the lung, kidney and spleen.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Vial size
- 100μg/vial
- Concentration
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
- Storage
- At -20°C for one year. After reconstitution, at 4°C for one month. It can also be aliquoted and stored frozen at -20°C for a longer time. Avoid repeated freezing and thawing.
- Handling
- Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Submitted references Convergent alteration of the mesenchymal stem cell heterogeneity in adipose tissue during aging.
Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.
IRS-1 targets TAZ to inhibit adipogenesis of rat bone marrow mesenchymal stem cells through PI3K-Akt and MEK-ERK pathways.
Liu Q, Zhao Y, Wang Q, Yan L, Fu X, Xiao R
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Aug;37(8):e23114
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2023 Aug;37(8):e23114
Sal B targets TAZ to facilitate osteogenesis and reduce adipogenesis through MEK-ERK pathway.
Wang N, Li Y, Li Z, Liu C, Xue P
Journal of cellular and molecular medicine 2019 May;23(5):3683-3695
Journal of cellular and molecular medicine 2019 May;23(5):3683-3695
IRS-1 targets TAZ to inhibit adipogenesis of rat bone marrow mesenchymal stem cells through PI3K-Akt and MEK-ERK pathways.
Wang N, Li Y, Li Z, Ma J, Wu X, Pan R, Wang Y, Gao L, Bao X, Xue P
European journal of pharmacology 2019 Apr 15;849:11-21
European journal of pharmacology 2019 Apr 15;849:11-21
No comments: Submit comment
Supportive validation
- Submitted by
- Boster Biological Technology (provider)
- Main image
- Experimental details
- Anti- CEBP Beta Picoband antibody, PB9171, IHC(P)IHC(P): Human Placenta Tissue
- Additional image